文献速递显微修复重建颅颌面外科

右旋糖酐对头颈显微重建术后血栓与血液稀释的影响

The Effects of Dextran on Postoperative Thrombosis and Hemodilution in Microvascular Head and Neck Reconstruction.
PubMed 文献 · Ann Plast Surg · 2020-01-01

该回顾性分析纳入176例头颈部游离皮瓣,比较术后使用右旋糖酐40联合低分子肝素与单用低分子肝素的结局。总皮瓣存活率90.34%,右旋糖酐组出血或血栓事件17例、对照组12例,两组其他并发症各13例。右旋糖酐40显著降低术后第1、3天红细胞计数、血红蛋白和血细胞比容,但不改善皮瓣存活,不建议常规使用。

要点

  • 右旋糖酐40不改善头颈游离皮瓣存活率,不建议常规使用。
  • 右旋糖酐40显著降低术后第1、3天红细胞计数、血红蛋白和血细胞比容。
  • 右旋糖酐40对术后血小板计数无显著影响。

核心结论

  • 右旋糖酐40虽有血液稀释作用,但未显示更好的皮瓣存活结局,且可能引起严重全身并发症,不宜常规给药。

研究设计与样本

  • 回顾性分析,纳入克罗地亚Zagreb大学医院4年间176例游离皮瓣,按术后预防方案分为右旋糖酐40组和未追加治疗组。

主要发现

  • 总皮瓣存活率90.34%,共16例完全坏死和1例部分坏死。
  • 27例吻合口探查中17例挽救成功。
  • 出血或动静脉血栓事件共29例:右旋糖酐组17例,对照组12例。
  • 其他术后并发症共26例,两组各13例。
  • 右旋糖酐组术后第1、3天红细胞计数、血红蛋白和血细胞比容显著降低,血小板计数无此效应。

临床怎么用

  • 头颈显微重建术后不推荐常规使用右旋糖酐40预防血栓。
  • 关注右旋糖酐40的血液稀释效应,但需权衡其全身并发症风险。

局限性

  • 回顾性设计,样本来自单中心,分组基于术后预防方案而非随机化。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Free tissue transfer is an integral part of reconstructive head and neck surgery today. Although increased experience and refinements in techniques have minimized flap loss, pharmacological agents have been used to prevent thrombus formation and flap failures, despite their questionable effectiveness. The aim of this study is to investigate the use of dextran 40 in thrombosis prophylaxis, as well as its effects on blood coagulability and flap survival. METHODS: This is a retrospective analysis of 176 free flaps performed at University Hospital Dubrava, Zagreb, Croatia, during a 4-year period. A comparison was made between 2 patient groups, based on their respective postoperative prophylaxis protocols. All patients were treated with low-molecular-weight heparin as deep vein thrombosis prevention, until patient mobilization. Group 1 was on dextran 40 protocol, whereas group 2 did not receive additional treatment. Primary outcome of the study was determined as flap loss rate, whereas secondary outcome was evaluated as the rate of thrombosis or hemorrhage. The hemodilution potential of dextran 40 was examined through blood count laboratory values. RESULTS: Total flap survival rate was 90.34%. There were 16 free flap losses and 1 partial loss overall. Anastomoses were re-explored in a total of 27 cases, of which 17 were salvaged. There were 29 events of hemorrhage or arterial or venous thrombosis: 17 in group 1 and 12 in group 2. A sum of 26 incidences of other postoperative complications was recorded, 13 in each group. Hemodilution status showed a statistically significant reduction in erythrocyte count and hemoglobin and hematocrit levels in the group receiving dextran 40, on postoperative days 1 and 3, but no such effect was observed on postoperative platelet count. CONCLUSIONS: Although dextran 40 has been shown to have a valuable effect on hemodilution, which is beneficial in microsurgery, it did not demonstrate better outcomes in terms of flap survival. Because it can cause serious systemic complications, it is better not to administer it routinely. However, its important influence on reduction in erythrocyte count and hemoglobin and hematocrit levels should be further investigated.

来源:Ann Plast Surg,查看原文。版权归原作者所有。

引用

  1. Filipan D, Dediol E, Blivajs I, et al. The Effects of Dextran on Postoperative Thrombosis and Hemodilution in Microvascular Head and Neck Reconstruction. Ann Plast Surg. 2020. PMID: 31904651. doi:10.1097/SAP.0000000000002148

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。